Latest Advances

  • Condition: ROS1-Rearranged Stage ?B Lung Adenocarcinoma
  • Journal: Journal for immunotherapy of cancer
  • Treatment Used: Ceritinib, Nivolumab plus Chemotherapy, Lorlatinbib
  • Number of Patients: 1
  • Published —
This case report describes a patient diagnosed with ROS1-rearranged non-small cell lung cancer (NSCLC) treated with ceritinib, nivolumab plus chemotherapy, and lorlatinbib.
  • Condition: Coronary Artery Fistula and Lung Adenocarcinoma
  • Journal: Annals of palliative medicine
  • Treatment Used: Artery Ligation and Pulmonary Lobectomy
  • Number of Patients: 1
  • Published —
This case report describes a patient with a coronary artery fistula and a lung adenocarcinoma.
  • Condition: Almonertinib-Induced Interstitial Lung Disease
  • Journal: Medicine
  • Treatment Used: Oxygen Uptake and Methylprednisolone
  • Number of Patients: 1
  • Published —
This case report describes a patient that experienced interstitial lung disease after treatment with almonertinib.
  • Condition: Drug-Induced Hypersensitivity Syndrome
  • Journal: Internal medicine (Tokyo, Japan)
  • Treatment Used: Prednisolone
  • Number of Patients: 1
  • Published —
This case report describes a patient with drug-induced hypersensitivity syndrome.
  • Condition: Lung Cancer
  • Journal: Anticancer research
  • Treatment Used: Osimertinib Plus Ramucirumab
  • Number of Patients: 6
  • Published —
The study researched the outcomes of osimertinib plus ramucirumab in treating Japanese lung cancer patients with EGFR-mutated lung adenocarcinoma.
  • Condition: COVID-19
  • Journal: mBio
  • Treatment Used: Stenoparib
  • Number of Patients: NULL
  • Published —
The study researched the effectiveness of stenoparib and remdesivir for COVID-19.
  • Condition: Advanced Lung Cancer
  • Journal: Technology in cancer research & treatment
  • Treatment Used: Systemic Chemotherapy Combined with Bronchoscopic Seed Implantation vs Systemic Chemotherapy
  • Number of Patients: 253
  • Published —
This study compared the value of systemic chemotherapy (works throughout the body) combined with bronchoscopic seed implantation (form of radiation therapy) versus systemic chemotherapy in patients with advanced lung cancer.
  • Condition: Metastatic Lung Adenocarcinoma
  • Journal: Frontiers in immunology
  • Treatment Used: PD-1 Inhibitor
  • Number of Patients: NULL
  • Published —
The study researched the outcomes of PD-1 inhibitor for metastatic lung adenocarcinoma.
  • Condition: Immune Checkpoint Inhibitor-Related Hyperprogressive Disease
  • Journal: Medicine
  • Treatment Used: Chemotherapy
  • Number of Patients: 1
  • Published —
The study researched the outcomes of a case of immune checkpoint inhibitor-related hyperprogressive disease.
  • Condition: Lung Adenocarcinoma
  • Journal: Medicine
  • Treatment Used: Crizotinib
  • Number of Patients: 1
  • Published —
The study researched a case of lung adenocarcinoma.
  • Condition: Lung Adenocarcinoma
  • Journal: Medicine
  • Treatment Used: Afatinib
  • Number of Patients: 1
  • Published —
The study researched the treatment of a patient with lung adenocarcinoma.
  • Condition: Pembrolizumab-Induced Recalcitrant Mixed Small and Medium Vessel Vasculitis
  • Journal: Dermatology online journal
  • Treatment Used: Glucocorticoids
  • Number of Patients: 1
  • Published —
This case report describes a patient with pembrolizumab-induced recalcitrant mixed small and medium vessel vasculitis that they developed from treatment for their rheumatoid arthritis and stage IV lung adenocarcinoma.
Showing 1-12 of 134